Borui medicine: successfully imitated, developed and produced redcivir API

Borui Pharmaceutical (688166) announced in the evening of February 11 that the company has recently successfully copied and developed the synthesis process technology and preparation technology of radcivir API The company has mass produced radcivir API, and the mass production of radcivir preparation is in progress After the company completes the imitation and preparation production of radcivir API, it needs to go through several links such as drug clinical trials, drug approval, etc If ridceway is finally converted into a product and put into the market, it needs to be authorized by Gilead as the patentee; there will be significant uncertainty in this process Penicillin statement: This article is reprinted by yaozhi.com The copyright belongs to the original author The purpose of reprint is to transmit more information, which does not represent the view of this platform If you are involved in the work content, copyright and other questions, please contact the official account message We will delete the content at the first time.